Of note, we clarified the underlying molecular mechanisms of METTL1‐mediated m7G tRNA modification, namely its regulation of EGFR/EFEMP1 translation, thus providing a theoretical basis for the development of novel targeted therapies against BC. Here, METTL1 is linked to breast cancer.